Evoke Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $4,283 | $3,752 | $3,080 | $3,308 |
Gross Profit | 4,182 | 3,584 | 3,038 | 3,189 |
EBITDA | -1,030 | -1,446 | -1,182 | -1,066 |
EBIT | -1,558 | -1,301 | 1,757 | |
Net Income | -1,156 | -1,570 | -1,306 | -1,192 |
Net Change In Cash | 4,283 | 3,752 | 3,080 | 3,308 |
Free Cash Flow | -521 | -565 | -997 | -1,240 |
Cash | 11,576 | 12,059 | 12,624 | 13,596 |
Basic Shares | 2,557 | 2,553 | 2,548 | 1,486 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,249 | $5,180 | $2,508 | $1,618 |
Gross Profit | 9,892 | 4,978 | 2,138 | 1,289 |
EBITDA | 353 | -7,153 | -7,724 | -8,037 |
EBIT | -4,850 | -7,292 | -7,724 | -8,037 |
Net Income | -5,352 | -7,792 | -8,224 | -8,537 |
Net Change In Cash | 10,249 | 5,180 | 2,508 | 1,618 |
Free Cash Flow | -5,458 | -4,984 | -6,595 | -12,352 |
Cash | 13,596 | 4,739 | 9,843 | 9,144 |
Basic Shares | 1,905 | 278 | 261 | 223 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.45 |
2025-06-30 | -$0.62 |
2025-03-31 | -$0.51 |
2024-12-31 | -$0.77 |
